dose escalation design with consideration of late onset toxicity
Published 8 years ago • 771 plays • Length 22:00Download video MP4
Download video MP3
Similar videos
-
1:11:44
east® 6.4 webinar: designing single and dual agent dose escalation trials
-
35:32
bayesian-based dose escalation clinical trial designs - pantelis vlachos, cytel
-
25:39
single and dual agent oncology dose-escalation designs in east® 6.4 - pantelis vlachos
-
1:16
modern dose escalation phase 1 trials with east® escalate
-
24:18
cytel and medidata: optimizing drug supply strategies with simulations
-
30:05
a competitive alternative to model-based dose escalation procedures
-
43:29
phase 1 dose escalation trials with escalate
-
11:25
a visual guide to bayesian thinking
-
58:26
adaptive trial designs - introduction for non-statisticians
-
37:34
designing first-in-human trials for small molecules and biologics
-
55:14
designs of dose escalation studies in phase i oncology trials
-
42:42
adaptive dose finding using toxicity probability intervals - neby bekele
-
1:28:09
adaptive dose-finding designs: improving development strategies
-
1:02:44
alternative methods to designing clinical trials in phase 1 oncology
-
49:05
key design considerations for basket and umbrella trials
-
41:53
optimizing development in early phase: mtpi case study, bayesian adaptive dose finding trials
-
1:00:50
design of adaptive phase 1 clinical trials for dose escalation using the deduce application
-
4:27
dose escalation results of ceritinib and nivolumab for alk nsclc
-
56:36
transforming oncology clinical development with adaptive studies